Literature DB >> 28526133

Metabolic Reprogramming and Oncogenesis: One Hallmark, Many Organelles.

A S H Costa1, C Frezza2.   

Abstract

The process of tumorigenesis can be described by a series of molecular features, among which alteration of cellular metabolism has recently emerged. This metabolic rewiring fulfills the energy and biosynthetic demands of fast proliferating cancer cells and amplifies their metabolic repertoire to survive and proliferate in the poorly oxygenated and nutrient-deprived tumor microenvironment. During the last decade, the complex reprogramming of cancer cell metabolism has been widely investigated, revealing cancer-specific metabolic alterations. These include dysregulation of glucose and glutamine metabolism, alterations of lipid synthesis and oxidation, and a complex rewiring of mitochondrial function. However, mitochondria are not the only metabolically active organelles within the cell, and other organelles, including lysosomes, peroxisomes, and endoplasmic reticulum, harbor components of the metabolic network. Of note, dysregulation of the function of these organelles is increasingly recognized in cancer cells. However, to what extent these organelles contribute to the metabolic reprogramming of cancer is not fully understood. In this review, we describe the main metabolic functions of these organelles and provide insights into how they communicate to orchestrate a coordinated metabolic reprogramming during transformation.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Compartmentalization; Metabolic cooperation; Metabolism; Organelle cross talk

Mesh:

Year:  2017        PMID: 28526133     DOI: 10.1016/bs.ircmb.2017.01.001

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  5 in total

Review 1.  Intercellular mitochondria trafficking highlighting the dual role of mesenchymal stem cells as both sensors and rescuers of tissue injury.

Authors:  Anne-Marie Rodriguez; Jean Nakhle; Emmanuel Griessinger; Marie-Luce Vignais
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

2.  Double genetic disruption of lactate dehydrogenases A and B is required to ablate the "Warburg effect" restricting tumor growth to oxidative metabolism.

Authors:  Maša Ždralević; Almut Brand; Lorenza Di Ianni; Katja Dettmer; Jörg Reinders; Katrin Singer; Katrin Peter; Annette Schnell; Christina Bruss; Sonja-Maria Decking; Gudrun Koehl; Blanca Felipe-Abrio; Jérôme Durivault; Pascale Bayer; Marie Evangelista; Thomas O'Brien; Peter J Oefner; Kathrin Renner; Jacques Pouysségur; Marina Kreutz
Journal:  J Biol Chem       Date:  2018-08-29       Impact factor: 5.157

Review 3.  Trial watch: dietary interventions for cancer therapy.

Authors:  Sarah Lévesque; Jonathan G Pol; Gladys Ferrere; Lorenzo Galluzzi; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2019-04-03       Impact factor: 8.110

Review 4.  How Far Are We from Prescribing Fasting as Anticancer Medicine?

Authors:  Maria V Deligiorgi; Charis Liapi; Dimitrios T Trafalis
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

5.  Pyruvate kinase variant of fission yeast tunes carbon metabolism, cell regulation, growth and stress resistance.

Authors:  Stephan Kamrad; Jan Grossbach; Maria Rodríguez-López; Michael Mülleder; StJohn Townsend; Valentina Cappelletti; Gorjan Stojanovski; Clara Correia-Melo; Paola Picotti; Andreas Beyer; Markus Ralser; Jürg Bähler
Journal:  Mol Syst Biol       Date:  2020-04       Impact factor: 13.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.